The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
Studies will Investigate Antidepressant Properties of Ketamir to Position for Initial IND Application in 2024
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
Demonstrate significant bleed reduction in hemophilia A and B
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Subscribe To Our Newsletter & Stay Updated
